The main active compound of scrophulariaceae extract is harpagoside ,and it is usually used as pharmaceuticals.There are few R&D enterprises for scrophulariaceae extract in China,in addition to the wildlife resources, Scrophulariaceaehas also been planted in Hunan but only with very small areas.
China is the main market Of harpagoside.The extraction process of harpagoside is not stable and the requirements for temperature and other parameters are high.At the same time, the price is relatively high and the supply specifications is mainly below 5%.Overall,very few companies are interested in the product because the demand is so limited.
Copyright Herbridge Media
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year

